Central anticholinergic syndrome secondary to atropine eye drops: A case study.
anticholinergic syndrome
atropine
eye drop
side effects
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
25
04
2022
received:
24
02
2022
accepted:
04
05
2022
pubmed:
18
5
2022
medline:
18
1
2023
entrez:
17
5
2022
Statut:
ppublish
Résumé
Atropine eye drops are frequently used in the treatment of keratitis and during ophthalmic surgery. We described a rare complication of central anticholinergic syndrome secondary to atropine eye drops.
Substances chimiques
Atropine
7C0697DR9I
Ophthalmic Solutions
0
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
541-543Informations de copyright
© 2022 British Pharmacological Society.
Références
Rupreht J, Dworacek B. The central anticholinergic syndrome in the postoperative period. Ann Fr Anesth Reanim. 1990;9(3):295-304. doi:10.1016/S0750-7658(05)80190-X
Melvin I. Roat, MD, FACS, Herpes simplex Keratisis, MSDManuals; https://www.msdmanuals.com/professional/eye-disorders/corneal-disorders/herpes-simplex-keratitis
Müller J, Wanke K. Toxic psychoses from atropine and scopolamine. Fortschr Neurol Psychiatr. 1998;66(07):289-295. doi:10.1055/s-2007-995265
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reaction. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154
Goodman LS, Gilman A. The Pharmacological Basis of Therapeutics. 12th ed. New York: Macmillan Publishing Co:100-120, 120-138, 235-257.
Schmoll S, Romanek K, Zorn G, Eiglmeier H, Eyer F. Anticholinergic syndrome after atropine overdose in a supposedly homeopathic solution: a case report. Clin Toxicol (Phila). 2021;14:1-3.
Panchasara A, Mandavia D, Anovadiya AP, Tripathi CB. Central anti-cholinergic syndrome induced by single therapeutic dose of atropine. Curr Drug Saf. 2012;7(1):35-36. doi:10.2174/157488612800492799
Rasiah S, Finger RP, MacIsaac AI, Lim LL. Takotsubo syndrome caused by subconjunctival injection of a mydricaine analogue. Clin Experiment Ophthalmol. 2016;44(7):624-625. doi:10.1111/ceo.12729
Keembiyage RD, Raymond GL, Newland HS. Atrial fibrillation following subconjunctival injection of mydricaine number 02. Clin Experiment Ophthalmol. 2006;34(8):806-808. doi:10.1111/j.1442-9071.2006.01331.x
Van Minderhout HM, Joosse MV, Grootendorst DC, Schalij-Delfos NE. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study. BMJ Open. 2015;5(12):e008798. doi:10.1136/bmjopen-2015-008798
Renko A, Cortese T, Karagiannis P, Salzman M. Unintentional cetirizine overdose causing anticholinergic syndrome: a case report. Am J Emerg Med. 2021;25S0735-6757(21):702-706.
Vidal. Atropine 1 pour cent, catégorie « mises en garde spéciales et précautions d'emploi ». Vidalédition; 2020.
Snir-Mori I, Weinstock M, Davidson JT, Bahar M. Physostigmine antagonizes morphine-induced respiratory depression in human subjects. Anesthesiology. 1993;59(1):6-9. doi:10.1097/00000542-198307000-00002
Baraka A, Harik S. Reversal of central anticholinergic syndrome by galanthamine. Jama. 1977;238(21):2293-2294. doi:10.1001/jama.1977.03280220061024
Rupreht J, Dworacek B. Central anticholinergic syndrome in anesthetic practice. Acta Anaesthesiol Belg. 1976;27(2):45-60.